Literature DB >> 2983869

Mucinous tumors of the ovary. A clinicopathologic study of 70 cases.

B A Chaitin, D M Gershenson, H L Evans.   

Abstract

Seventy cases of mucinous ovarian tumor were reviewed. All patients were followed for a minimum of 5 years. Clinicopathologically, three groups were defined: (1) mucinous cystadenoma, which demonstrated no nuclear stratification and no stromal invasion (15 cases); (2) mucinous tumor of uncertain malignant potential, which was characterized by nuclear stratification of two to three layers and no stromal invasion (21 cases); and (3) mucinous carcinoma, which showed stromal invasion and/or nuclear stratification in excess of three layers (34 cases; 15 with invasion, 19 without). All patients with mucinous cystadenomas remained tumor-free after initial surgery. Two patients with mucinous tumors of uncertain malignant potential died of tumor at 55 and 72 months, respectively, whereas 18 with mucinous carcinomas died after intervals ranging from 2 to 71 months. All mucinous tumors of uncertain malignant potential were Stage I at presentation. Twenty-one mucinous carcinomas were Stage I (six tumor deaths), one was Stage II (tumor death), ten were Stage III (nine tumor deaths), one was Stage IV (tumor death), and one was of uncertain stage (tumor death). Patients with mucinous carcinomas having stromal invasion demonstrated poorer survival (10 of 15 dead) than those with mucinous carcinomas lacking this finding (8 of 19 dead); however, stromal invasion was related to higher stage (5 with invasion Stage I; 16 without invasion Stage I).

Entities:  

Mesh:

Year:  1985        PMID: 2983869     DOI: 10.1002/1097-0142(19850501)55:9<1958::aid-cncr2820550921>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.

Authors:  Richard J Zaino; Mark F Brady; Subodh M Lele; Helen Michael; Benjamin Greer; Michael A Bookman
Journal:  Cancer       Date:  2010-09-22       Impact factor: 6.860

2.  Mucinous cystadenoma of the ovary in perimenarchal girls.

Authors:  T Sri Paran; A Mortell; D Devaney; A Pinter; P Puri
Journal:  Pediatr Surg Int       Date:  2006-01-17       Impact factor: 1.827

3.  Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute.

Authors:  Ghada Sahraoui; Asma Fitouri; Lamia Charfi; Maha Driss; Maher Slimane; Monia Hechiche; Karima Mrad; Raoudha Doghri
Journal:  Pan Afr Med J       Date:  2022-04-29

4.  Mucinous Cystadenoma in Children and Adolescents.

Authors:  Renee A Cowan; Erin N Haber; Fabio R Faucz; Constantine A Stratakis; Veronica Gomez-Lobo
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-02-16       Impact factor: 1.814

Review 5.  Borderline ovarian tumors: a review of treatment.

Authors:  J T Chambers
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug

6.  Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology.

Authors:  Hiroaki Kajiyama; Kiyosumi Shibata; Mika Mizuno; Tomokazu Umezu; Shiro Suzuki; Ryuichiro Sekiya; Kaoru Niimi; Hiroko Mitsui; Eiko Yamamoto; Michiyasu Kawai; Tetsuro Nagasaka; Fumitaka Kikkawa
Journal:  J Gynecol Oncol       Date:  2014-01-08       Impact factor: 4.401

7.  Incidental discovery of a giant ovarian cystadenoma.

Authors:  Bouali Mounir; Elwassi Anas; Eddaoudi Yassine; El Bakouri Abdelilah; El Hattabi Khalid; Fatimazahra Bensardi; Fadil Abdelaziz
Journal:  Ann Med Surg (Lond)       Date:  2022-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.